Search Medical Condition
Please enter condition
Please choose location from dropdown

Yangsan-si, Korea, Republic of Clinical Trials

A listing of Yangsan-si, Korea, Republic of clinical trials actively recruiting patients volunteers.

RESULTS

Found (50) clinical trials

Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma

Urothelial carcinoma is the fifth most common cancer in men and seventh among women all around the world. Although a complete surgical resection with or without perioperative treatment is the most effective way to offer a potentially curative therapy to patients with these cancers, 25% of the patients initially present ...

Phase

0.0 miles

Learn More »

Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions

The purpose of this study is to evaluate the effect of FFR (Fractional flow reserve) guided Percutaneous Coronary Intervention in coronary tandem lesions.

Phase N/A

0.0 miles

Learn More »

Observational Study of the Conjugated Rehabilitation on Children With Cerebral Palsy

Survey An interview survey on baseline Basic characteristics Cause of cerebral palsy Accompanied disorders Health problems Operation history Drug-taking Rehabilitation treatment Korean medicine treatment Health functional food Medical care cost An interview survey on 26th and 52nd weeks Accompanied disorders Health problems A weekly tracking survey Health problems Therapeutic change ...

Phase N/A

0.0 miles

Learn More »

A Study to Evaluate Safety Efficacy Pharmacokinetics and Pharmacodynamics of Erdafitinib Plus JNJ-63723283 (Cetrelimab) an Anti-PD-1 Monoclonal Antibody in Participants With Metastatic or Locally Advanced Urothelial Cancer With Selected FGFR Gene Alterations

This open-label (all people know identity of intervention) and multicenter (when more than one hospital or medical school team work on a medical research study) study of erdafitinib plus cetrelimab in participants with advanced urothelial cancer with selected fibroblast growth factor receptor (FGFR) gene alterations, will consists of 2 parts. ...

Phase

0.0 miles

Learn More »

IRIS-Onyx Cohort in the IRIS-DES Registry

The purpose of this study is to evaluate the relative effectiveness and safety of Onyx stent compared to other (drug eluting stents) DES.

Phase N/A

0.0 miles

Learn More »

Post Marketing Surveillance on Safety Evaluation of POMALYST (Pomalidomide) Treatment of Multiple Myeloma in Korea

PMS period: 09Jun2017 ~ 08Jun2023 Target no.: 600patients indication: POMALYST in combination with dexamethasone is indicated in the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib The primary objective of this Drug Use Examination (DUE) ...

Phase N/A

0.0 miles

Learn More »

Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients

There are approximately 20 percent patients of refractory cancer pain, which is troubled with uncontrolled pain though treatment including opioids. Ketamine has been showed the performance of Ketamine, N-methyl-D-aspartate (NMDA) receptor blocker, in refractory cancer pain based on prior studies. We cannot yet confirm the role of Ketamine comparing the ...

Phase

0.0 miles

Learn More »

Effect of Sugammadex vs. Neostigmine/Glycopyrrolate on Pediatric Emergence Delirium in Sevoflurane-rocuronium Anesthesia

The aim of this study is to investigate the effect of sugammadex vs. a conventional acetylcholinesterase inhibitor, neostigmine on emergence delirium (ED) during sevoflurane-rocuronium anesthesia in pediatric patients Additionally, the efficacy features of sugammadex compared to neostigmine will be examined by measuring the time from start of administration of reversal ...

Phase

0.0 miles

Learn More »

Deltyba Registry in MDR-TB Patients

Deltyba Registry aims to collect the usage information of Deltyba which could be a factor of developing resistance in actual clinical settings.

Phase N/A

0.0 miles

Learn More »

Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation ...

Phase

0.0 miles

Learn More »